Innovative Product Focus Silo is actively developing advanced therapeutics for PTSD and stress-related conditions, offering potential partnership or contract opportunities in clinical research services, drug formulation, and delivery systems targeting mental health solutions.

Strong R&D Pipeline With plans to submit an IND to the FDA and advancing Phase 1 studies, Silo presents opportunities to collaborate on regulatory consulting, clinical trial management, and medical writing services tailored for early-stage biotech companies.

Digital Asset Integration Silo's strategic investments in cryptocurrencies and blockchain-based assets reveal a unique opening for fintech or blockchain technology providers to engage in digital treasury management solutions or crypto-related financial services.

Growth Through Diversification The company's allocation of assets on the Solana blockchain and involvement in DeSci platforms demonstrate a potential market for digital asset platforms, DeFi solutions, and tokenization services aimed at biotech or pharmaceutical sectors.

Market Expansion Potential As a NASDAQ-listed small-cap company with recent partnership announcements and innovative initiatives, Silo is positioned for growth, representing opportunities to provide sales and marketing support, investor relations, or strategic consulting to expand their market reach.